?> Contact us Follow Us
Biosimilars Forum
  • About Us
    • Members
    • Executive Director
  • Why Biosimilars
    • The Issue
    • Our Solutions
  • Biosimilars 101
    • Foundations
    • Core Principles
    • FDA Regulatory Tenets
    • Biosimilars FAQs
    • Future Evolution of Biosimilar Development
    • Approved Biosimilars
  • Advocacy
    • Our Action
    • Tools
  • News
  • Resources
  • Get Involved
    • Partners

Katie Quinn

Get more out of your business.
Reach it with Microsoft Dynamics 365 Business Central.
News
July 12, 2018 Katie Quinn
Biosimilars Forum Commends FDA Commissioner For Raising Awareness Of Biosimilars
News
July 9, 2018 Katie Quinn
Biosimilars Forum Convenes Stakeholder Groups to Discuss Advancing Biosimilars
News
June 27, 2018 Katie Quinn
Biosimilars Forum Releases Position on Non-Medical Switching
News
June 21, 2018 Katie Quinn
Biosimilars Forum Applauds FDA Decision to Reevaluate Draft Guidance
News
May 16, 2018 Katie Quinn
Biosimilars Forum Applauds Approval of 10th Biosimilar in United States
News
May 11, 2018 Katie Quinn
Biosimilars Forum Encouraged by Trump Administration’s Support for Biosimilars
News
March 9, 2018 Katie Quinn
Biosimilars Forum Encouraged By Food And Drug Administration Commissioner’s Support of Biosimilars
News
February 22, 2018 Katie Quinn
Biosimilars Forum Opposes Efforts to Prohibit Biosimilars From Receiving Pass-Through Payment Status
News
February 12, 2018 Katie Quinn
Biosimilars Forum Supports Inclusion of Biosimilars in the Medicare Coverage Gap Discount Program
News
November 2, 2017 Katie Quinn
Biosimilars Forum Applauds CMS Decision to Reverse Existing Rule on Biosimilar Reimbursement Policy
  • Prev page
  • 02
  • 03
  • 04
  • 05
  • 06
  • Next page

  • Biosimilars 101
  • Biosimilars FAQs
  • Advocacy
  • Stay Connected
Biosimilars Forum
© 2025 Biosimilars Forum. All rights reserved.
  • Terms of Use
  • |
  • Privacy Policy
  • |
  • Contact Us